Myopia Management

Myopia management is a proactive strategy designed to slow the progression of nearsightedness in children rather than simply correcting distance vision. Standard glasses or contact lenses correct current refractive error, while myopia control aims to reduce the rate of prescription change over time. The underlying goal is to lower the lifetime risk of high myopia and its associated complications by intervening during the period of rapid eye growth.

Myopia management uses evidence-based options such as specialty contact lenses, orthokeratology, low-dose atropine drops, and purpose-built spectacle lenses to alter the visual signals that influence eye growth. Each approach works in a different way and may be selected based on the child’s age, prescription, and lifestyle. Effective myopia management always includes ongoing measurement and adjustments to the plan as the child grows.

Children who are already nearsighted and those with a family history of progressive myopia are common candidates for myopia management. Early onset of myopia, rapid increases in prescription from year to year, and certain lifestyle factors such as extensive near work or limited outdoor time can all increase the likelihood that intervention will be beneficial. An initial assessment helps determine whether a child’s current eye measurements and risk profile warrant treatment.

At A Visual Affair we evaluate each child’s refractive error, eye growth measurements, and visual needs before recommending a program. The decision to begin myopia control is individualized and typically favors starting earlier when progression is more likely to be rapid. Regular follow-up allows clinicians to reassess candidacy and modify the approach if needed.

There are several clinically supported options for myopia control, including specialty soft contact lenses designed to create peripheral defocus, overnight orthokeratology lenses that reshape the cornea temporarily, low-dose atropine eye drops, and spectacle lenses engineered to slow axial elongation. Each method targets factors that contribute to eye growth and has different practical considerations, such as wear schedule and care requirements. The choice of therapy depends on the child’s age, prescription, ocular health, and family preferences.

No single option is universally best, and treatment plans are often tailored to balance effectiveness with lifestyle and safety. Some children do well with contact lens–based approaches, while others may be better suited to atropine or specialized glasses. Our role is to explain the evidence, expected outcomes, and monitoring needs so families can make an informed decision.

Orthokeratology, often called ortho-k, uses specially designed rigid gas-permeable contact lenses worn overnight to temporarily reshape the cornea and reduce daytime myopia. When used as part of a myopia management program, ortho-k can provide clear vision during the day without glasses while also slowing axial elongation in many children. The fitting process requires precise measurements of the cornea and close supervision during the adaptation period.

Parents should expect an initial series of visits for lens fitting, instruction on lens care, and early follow-up to assess fit and vision. After the first few weeks, maintenance visits are typically scheduled at regular intervals to check eye health, corneal shape, and refractive status. Good lens hygiene and adherence to follow-up are important to minimize risks and maximize benefits.

Low-dose atropine eye drops are prescribed in concentrations much lower than those used historically for dilating the pupil; these low doses have been shown to reduce the rate of myopia progression in many clinical studies. Treatment usually involves nightly administration under clinical supervision, with regular monitoring for efficacy and any side effects. Common side effects at low concentrations are generally mild and can include slight light sensitivity or near focusing changes in some children.

Safety is an important consideration, so clinicians monitor each child’s response and adjust treatment if necessary. The decision to use atropine is individualized and takes into account the child’s age, progression rate, and tolerance for potential side effects. Long-term plans often combine atropine with regular eye measurements and follow-up to ensure the best possible outcome.

Myopia management requires a schedule of regular follow-up visits to track eye growth, refractive changes, and treatment effectiveness. Typical monitoring intervals range from every three to six months, with more frequent checks early in treatment or when adjustments are being made. Visits generally include refraction, visual acuity testing, and measurements such as axial length to quantify changes in eye growth.

Consistent follow-up is essential because treatment plans are adjusted based on objective findings rather than symptoms alone. During visits the clinician will review progress, check ocular health, and discuss any practical concerns about lenses, drops, or glasses. This structured follow-up helps ensure that the chosen strategy continues to deliver the intended benefit as the child grows.

Slowing myopia progression can offer both immediate and long-term advantages, including fewer prescription changes and better unaided vision during childhood. More importantly, reducing the degree of myopia achieved by adulthood lowers the lifetime risk of sight-threatening complications such as retinal detachment, myopic maculopathy, and glaucoma. The magnitude of risk increases with higher levels of myopia, which is why early management can be clinically meaningful.

Addressing myopia progression is a preventive approach that aims to protect ocular health decades into the future. While no method guarantees elimination of all risk, clinical evidence indicates that slowing axial elongation during childhood reduces the likelihood of severe refractive error later on. Regular eye care and appropriate myopia control strategies are key elements of long-term vision preservation.

Yes, myopia management can sometimes be integrated with other vision care interventions, but combinations are selected carefully and supervised by the eye doctor. For example, certain patients might use a contact lens–based approach while also undergoing spectacle correction for specific activities, or atropine may be recommended alongside lifestyle adjustments. Each combined approach is based on clinical rationale and evidence where available, and is tailored to the child’s overall eye health and needs.

Decisions about combining treatments take into account effectiveness, safety, and the potential for added benefit versus complexity. Your eye doctor will review current research, track outcomes closely, and modify the plan if one strategy alone proves sufficient or if a combined approach offers a better risk–benefit profile. Ongoing monitoring remains essential whenever therapies are used together.

Earlier intervention tends to offer greater potential to slow myopia progression because eye growth occurs most rapidly in younger children. Many clinicians consider beginning myopia management as soon as nearsightedness is identified in a child who shows evidence of progression or who has risk factors such as a strong family history. The timing is individualized, and a thorough baseline assessment helps determine the best moment to start treatment.

Myopia management usually continues throughout the period of active eye growth, which commonly extends through the teenage years until refractive error stabilizes. The exact duration varies by individual and is guided by serial measurements of axial length and refraction. Treatment plans are periodically reassessed and may be tapered or stopped once progression is minimal or has ceased.

Essilor Stellest lenses are myopia control glasses that correct your child's distance vision and slow the progression of nearsightedness at the same time. In September 2025 they became the first spectacle lens authorized by the FDA for slowing myopia progression, in children ages 6 to 12 at the start of treatment. The lens has a clear central zone that corrects vision normally, ringed by eleven circles of more than a thousand microscopic aspherical lenslets in a design Essilor calls H.A.L.T. technology. Those lenslets focus some light just in front of the retina rather than on it, which creates a signal that slows the elongation of the eye behind a worsening prescription.

In a two-year randomized clinical trial conducted at nine sites in the United States, children wearing Stellest progressed 71% less, and their eyes elongated 53% less, than children wearing standard single-vision lenses, and three out of four eyes in the Stellest group changed by less than half a diopter over the full two years. No serious adverse events were reported, though a small number of children notice mild blur or halos toward the edges of their vision while adapting. Because Stellest looks and wears like an ordinary pair of glasses, it is often the easiest starting point for families who are not comfortable with contact lenses, overnight retainer lenses, or nightly eye drops.

Stellest lenses should be worn at least 12 hours a day, every day, including weekends and school holidays. That number is not arbitrary. The published clinical results, including the 71% reduction in myopia progression and 53% reduction in eye elongation measured over two years, were achieved by children who wore the lenses full time. Children who wear them only part of the day get less benefit, because the lenses can only send the slow-down signal to the eye while they are actually on the face.

In practice this means Stellest works best as your child's everyday pair rather than a backup, so it is worth planning for a durable frame and, for active kids, a spare pair. If your child plays sports, spends long stretches in sunglasses, or tends to take glasses off at home, let us know and we will work through the daily routine with you. We track prescription and axial length at each follow-up visit, which tells us both how well the lenses are controlling progression and whether wearing time needs attention.

A myopia management consultation at A Visual Affair begins with a comprehensive eye exam that includes a detailed refractive assessment, measurement of axial length when indicated, and evaluation of ocular health. The visit typically involves discussion of family history, visual habits, and lifestyle factors that influence myopia progression. These baseline tests provide the objective data needed to recommend appropriate treatment options and monitoring intervals.

Following the exam, the doctor will explain the evidence-based options that fit the child’s profile, outline a recommended follow-up schedule, and answer practical questions about lens wear or drop use. If a treatment is initiated, we provide education on usage, safety, and the importance of adherence and regular visits at our Arlington or Washington, D.C., locations. Ongoing communication and measurement are central to achieving the best possible outcome for each child.